Clinical Trial Detail

NCT ID NCT03300609
Title 5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements yes
Sponsors University of Southern California
Indications

colorectal adenocarcinoma

Therapies

Capecitabine

Panitumumab + FOLFOX

Panitumumab + Fluorouracil + Leucovorin

Age Groups: adult senior

Additional content available in CKB BOOST